SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Batu Biologics, an immuno-oncology company, announced Wednesday that it has successfully completed a $1 million seed round of funding.
Tocagen Inc., a biopharmaceutical company, announced that Asha Das has been named vice president of clinical development and medical affairs.
HUYA Bioscience International announced Tuesday that it has appointed Bob Goodenow as chief business officer.
San Diego-based Pathway Genomics Corp. announced that former U.S. Secretary of Commerce Barbara Franklin is joining the company's board of directors.
San Diego-based Millennium Health and its population health management subsidiary, RxAnte LLC, announced a new suite of integrated services to address the growing epidemic of unsafe use of prescription pain medicines known as opioids.
San Diego-based Ligand Pharmaceuticals Inc. announced Friday that the Food and Drug Administration has approved a new drug application for the use of Promacta, a drug that Ligand co-developed with British drugmaker GlaxoSmithKline.
BitCot Inc., a small startup in San Diego, has won an innovation contest hosted by Santa Cruz electronics giant Plantronics by connecting first responders with car accident victims.
LEADERSHIP: C-Suite Shakeups Hit Local Scene
A corner of San Diego’s life science cluster is experiencing an unexpected executive shuffle, with several C-suites reorganizing under new leadership.
Palomar Health may close its downtown Escondido hospital, the board announced Thursday. The 65-year-old hospital building between Grand Avenue and Valley Parkway is losing about $20 million per year and may need to close within the next few months.
Illumina Inc. has entered into an agreement with a Beijing diagnostics firm that will employ next-generation sequencing technology to improve health care in China.
San Diego-based Arcturus Therapeutics Inc. announced Thursday that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals Inc.
BioAtla LLC announced Thursday that a China-based investor group has purchased $30 million in BioAtla equity.
San Diego-based Ignyta Inc. announced Tuesday that it will sell about $75 million of its common stock in an underwritten public offering.
San Diego 3-D bioprinting company Organovo Holdings Inc. reported a net loss of $30 million for the 2015 fiscal year on revenues of $571,000, according to an annual financial statement.
The Sanford Consortium for Regenerative Medicine and Japan-based Takeda Pharmaceutical Co. Ltd. have established a $10 million, five-year Innovation Alliance to identify translational research and proof-of-concept projects for therapeutics.